Cover Image
Market Research Report
Product code
914144

Latin America, Middle East & Africa Spinal Cord Stimulation Devices Market (2019-2025)

Published: | KBV Research | 72 Pages | Delivery time: 1-2 business days

Price

Back to Top
Latin America, Middle East & Africa Spinal Cord Stimulation Devices Market (2019-2025)
Published: September 30, 2019
KBV Research
Content info: 72 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The Latin America, Middle East and Africa Spinal Cord Stimulation Devices Market would witness market growth of 9.06% CAGR during the forecast period (2019-2025). The growing amount of chronic and neuropathic pains in patients and the simultaneous introduction of new products by leading companies is further pushing the industry growth.

Spinal cord stimulation is referred to as a neuro-stimulation treatment that cures specific pain conditions like chronic pain. The stimulation process uses stimulators to block the pain signals before they reach the brain. A stimulator device is implanted under the patients' skin and it sends electric signals to the specified areas of the spinal cord for treating the pain. When the stimulator device is switched on, it modifies the pain signal that travels to the brain. It contains a small wire which carries electrical signals to transmit it towards the nerve fibers of a spinal cord. With this capability, spinal cord stimulation devices can effectively help to reduce the pain due to electrical pulses and mask the pain signal from reaching the patient's brain.

Based on Product, the market is segmented into Rechargeable and Non-Rechargeable. Based on Application, the market is segmented into Complex Regional Pain Syndrome, Unsuccessful Disk Surgery, Failed Back Syndrome, Degenerative Disk Disease and Other Applications. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories (St. Jude Medical, Inc.), Neurosigma, Inc., Nevro Corporation, Synapse BioMedical, Inc., Integer Holdings Corporation, Stimwave Technologies, Inc., Nuvectra Corporation and Saluda Medical Pty Ltd.

Scope of the Study

Market Segmentation:

By Product

  • Rechargeable
  • Non-Rechargeable

By Application

  • Complex Regional Pain Syndrome
  • Unsuccessful Disk Surgery
  • Failed Back Syndrome
  • Degenerative Disk Disease
  • Other Applications

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled:

  • Boston Scientific Corporation
  • Medtronic PLC
  • Abbott Laboratories (St. Jude Medical, Inc.)
  • Neurosigma, Inc.
  • Nevro Corporation
  • Synapse BioMedical, Inc.
  • Integer Holdings Corporation
  • Stimwave Technologies, Inc.
  • Nuvectra Corporation
  • Saluda Medical Pty Ltd.

Unique Offerings from KBV Research:

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Table of Contents

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Spinal Cord Stimulation Devices Market, by Product
    • 1.4.2 LAMEA Spinal Cord Stimulation Devices Market, by Application
    • 1.4.3 LAMEA Spinal Cord Stimulation Devices Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. LAMEA Spinal Cord Stimulation Devices Market by Applications

  • 3.1 LAMEA Complex Regional Pain Syndrome Market by Country
  • 3.2 LAMEA Unsuccessful Disk Surgery Market by Country
  • 3.3 LAMEA Failed Back Syndrome Market by Country
  • 3.4 LAMEA Degenerative Disk Disease Market by Country
  • 3.5 LAMEA Other Applications Market by Country

Chapter 4. LAMEA Spinal Cord Stimulation Devices Market by Product

  • 4.1 LAMEA Rechargeable Market by Country
  • 4.2 LAMEA Non-Rechargeable Market by Country

Chapter 5. LAMEA Spinal Cord Stimulation Devices Market by Country

  • 5.1 Brazil Spinal Cord Stimulation Devices Market
    • 5.1.1 Brazil Spinal Cord Stimulation Devices Market by Applications
    • 5.1.2 Brazil Spinal Cord Stimulation Devices Market by Product
  • 5.2 Argentina Spinal Cord Stimulation Devices Market
    • 5.2.1 Argentina Spinal Cord Stimulation Devices Market by Applications
    • 5.2.2 Argentina Spinal Cord Stimulation Devices Market by Product
  • 5.3 UAE Spinal Cord Stimulation Devices Market
    • 5.3.1 UAE Spinal Cord Stimulation Devices Market by Applications
    • 5.3.2 UAE Spinal Cord Stimulation Devices Market by Product
  • 5.4 Saudi Arabia Spinal Cord Stimulation Devices Market
    • 5.4.1 Saudi Arabia Spinal Cord Stimulation Devices Market by Applications
    • 5.4.2 Saudi Arabia Spinal Cord Stimulation Devices Market by Product
  • 5.5 South Africa Spinal Cord Stimulation Devices Market
    • 5.5.1 South Africa Spinal Cord Stimulation Devices Market by Applications
    • 5.5.2 South Africa Spinal Cord Stimulation Devices Market by Product
  • 5.6 Nigeria Spinal Cord Stimulation Devices Market
    • 5.6.1 Nigeria Spinal Cord Stimulation Devices Market by Applications
    • 5.6.2 Nigeria Spinal Cord Stimulation Devices Market by Product
  • 5.7 Rest of LAMEA Spinal Cord Stimulation Devices Market
    • 5.7.1 Rest of LAMEA Spinal Cord Stimulation Devices Market by Applications
    • 5.7.2 Rest of LAMEA Spinal Cord Stimulation Devices Market by Product

Chapter 6. Company Profiles

  • 6.1 Boston Scientific Corporation
    • 6.1.1 Company Overview
    • 6.1.2 Financial Analysis
    • 6.1.3 Segmental and Regional Analysis
    • 6.1.4 Research & Development Expense
    • 6.1.1 Recent strategies and developments:
      • 6.1.1.1 Product launches:
      • 6.1.1.2 Acquisition and mergers:
      • 6.1.1.3 Collaborations, partnerships and agreements:
  • 6.2 Medtronic PLC
    • 6.2.1 Company overview
    • 6.2.2 Financial Analysis
    • 6.2.3 Segmental and Regional Analysis
    • 6.2.4 Research & Development Expenses
    • 6.2.5 Recent strategies and developments:
      • 6.2.5.1 Product launches:
      • 6.2.5.2 Approvals:
  • 6.3 Abbott Laboratories (St. Jude Medical, Inc.)
    • 6.3.1 Company Overview
    • 6.3.2 Financial Analysis
    • 6.3.3 Segmental and Regional Analysis
    • 6.3.4 Research & Development Expense
    • 6.3.5 Recent strategies and developments:
      • 6.3.5.1 Product launches:
      • 6.3.5.2 Collaborations, partnerships and agreements:
      • 6.3.5.3 Acquisition and mergers:
  • 6.4 Neurosigma, Inc.
    • 6.4.1 Company Overview
  • 6.5 Nevro Corporation
    • 6.5.1 Company Overview
    • 6.5.2 Financial Analysis
    • 6.5.3 Regional Analysis
    • 6.5.4 Research & Development Expense
    • 6.5.5 Recent strategies and developments:
      • 6.5.5.1 Approvals:
  • 6.6 Synapse BioMedical, Inc.
    • 6.6.1 Company Overview
    • 6.6.2 Recent strategies and developments:
      • 6.6.2.1 Collaborations, partnerships and agreements:
  • 6.7 Integer Holdings Corporation
    • 6.7.1 Company Overview
    • 6.7.2 Financial Analysis
    • 6.7.3 Segmental and Regional Analysis
    • 6.7.4 Research & Development Expense
  • 6.8 Stimwave Technologies, Inc.
    • 6.8.1 Company Overview
    • 6.8.2 Recent strategies and developments:
      • 6.8.2.1 Approvals:
  • 6.9 Nuvectra Corporation
    • 6.9.1 Company Overview
    • 6.9.2 Financial Analysis
    • 6.9.3 Regional Analysis
    • 6.9.4 Research & Development Expense
    • 6.9.5 Recent strategies and developments:
      • 6.9.5.1 Approvals:
  • 6.1 Saluda Medical Pty Ltd.
    • 6.10.1 Company Overview
    • 6.10.2 Recent strategies and developments:
      • 6.10.2.1 Product launches:

LIST OF TABLES

  • TABLE 1 LAMEA SPINAL CORD STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
  • TABLE 2 LAMEA SPINAL CORD STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
  • TABLE 3 LAMEA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
  • TABLE 4 LAMEA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
  • TABLE 5 LAMEA COMPLEX REGIONAL PAIN SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 6 LAMEA COMPLEX REGIONAL PAIN SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 7 LAMEA UNSUCCESSFUL DISK SURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 8 LAMEA UNSUCCESSFUL DISK SURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 9 LAMEA FAILED BACK SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 10 LAMEA FAILED BACK SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 11 LAMEA DEGENERATIVE DISK DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 12 LAMEA DEGENERATIVE DISK DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 13 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 14 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 15 LAMEA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
  • TABLE 16 LAMEA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
  • TABLE 17 LAMEA RECHARGEABLE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 18 LAMEA RECHARGEABLE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 19 LAMEA NON-RECHARGEABLE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 20 LAMEA NON-RECHARGEABLE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 21 LAMEA SPINAL CORD STIMULATION DEVICES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 22 LAMEA SPINAL CORD STIMULATION DEVICES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 23 BRAZIL SPINAL CORD STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
  • TABLE 24 BRAZIL SPINAL CORD STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
  • TABLE 25 BRAZIL SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
  • TABLE 26 BRAZIL SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
  • TABLE 27 BRAZIL SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
  • TABLE 28 BRAZIL SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
  • TABLE 29 ARGENTINA SPINAL CORD STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
  • TABLE 30 ARGENTINA SPINAL CORD STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
  • TABLE 31 ARGENTINA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
  • TABLE 32 ARGENTINA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
  • TABLE 33 ARGENTINA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
  • TABLE 34 ARGENTINA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
  • TABLE 35 UAE SPINAL CORD STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
  • TABLE 36 UAE SPINAL CORD STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
  • TABLE 37 UAE SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
  • TABLE 38 UAE SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
  • TABLE 39 UAE SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
  • TABLE 40 UAE SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
  • TABLE 41 SAUDI ARABIA SPINAL CORD STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
  • TABLE 42 SAUDI ARABIA SPINAL CORD STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
  • TABLE 43 SAUDI ARABIA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
  • TABLE 44 SAUDI ARABIA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
  • TABLE 45 SAUDI ARABIA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
  • TABLE 46 SAUDI ARABIA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
  • TABLE 47 SOUTH AFRICA SPINAL CORD STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
  • TABLE 48 SOUTH AFRICA SPINAL CORD STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
  • TABLE 49 SOUTH AFRICA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
  • TABLE 50 SOUTH AFRICA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
  • TABLE 51 SOUTH AFRICA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
  • TABLE 52 SOUTH AFRICA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
  • TABLE 53 NIGERIA SPINAL CORD STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
  • TABLE 54 NIGERIA SPINAL CORD STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
  • TABLE 55 NIGERIA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
  • TABLE 56 NIGERIA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
  • TABLE 57 NIGERIA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
  • TABLE 58 NIGERIA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
  • TABLE 59 REST OF LAMEA SPINAL CORD STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
  • TABLE 60 REST OF LAMEA SPINAL CORD STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
  • TABLE 61 REST OF LAMEA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
  • TABLE 62 REST OF LAMEA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
  • TABLE 63 REST OF LAMEA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
  • TABLE 64 REST OF LAMEA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
  • TABLE 65 KEY INFORMATION - BOSTON SCIENTIFIC CORPORATION
  • TABLE 66 KEY INFORMATION - MEDTRONIC PLC
  • TABLE 67 KEY INFORMATION - ABBOTT LABORATORIES
  • TABLE 68 KEY INFORMATION - NEUROSIGMA, INC.
  • TABLE 69 KEY INFORMATION - NEVRO CORPORATION
  • TABLE 70 KEY INFORMATION - SYNAPSE BIOMEDICAL, INC.
  • TABLE 71 KEY INFORMATION -INTEGER HOLDINGS CORPORATION
  • TABLE 72 KEY INFORMATION - STIMWAVE TECHNOLOGIES, INC.
  • TABLE 73 KEY INFORMATION - NUVECTRA CORPORATION
  • TABLE 74 KEY INFORMATION - SALUDA MEDICAL PTY LTD.

LIST OF FIGURES